Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology

Autor:	C. Boutwell, Z. El-Chami, H. Ali, R. M. Dubinsky, H. Kabbani
Rok vydání:	2004
Předmět:	medicine.medical_specialty Gabapentin Cyclohexanecarboxylic Acids MEDLINE Pregabalin Anti-Inflammatory Agents Cochrane Library Antidepressive Agents Tricyclic Administration Cutaneous Antiviral Agents Herpes Zoster Receptors N-Methyl-D-Aspartate Double-Blind Method medicine Humans Acupuncture Analgesia Amines Intensive care medicine gamma-Aminobutyric Acid Randomized Controlled Trials as Topic Analgesics Clinical Trials as Topic Evidence-Based Medicine Postherpetic neuralgia business.industry Lidocaine Number needed to harm Iontophoresis medicine.disease nervous system diseases Surgery body regions Analgesics Opioid Neuralgia Number needed to treat Drug Evaluation Anticonvulsants Neurology (clinical) business Excitatory Amino Acid Antagonists medicine.drug Forecasting
Zdroj:	Neurology. 63(6)
ISSN:	1526-632X
Popis:	A systematic review of the literature on postherpetic neuralgia was performed. The authors identified studies using the National Library of Medicine's Medline database and Cochrane Library database. The authors determined absolute reduction rate, number needed to treat (NNT), 95% CI for NNT, and number needed to harm (NNH) for successful therapies of postherpetic neuralgia. Tricyclic antidepressants, gabapentin, pregabalin, opioids, and lidocaine patch were found to be effective in reducing the pain of postherpetic neuralgia.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bde0594bb7436043521339cc1cbb622 https://pubmed.ncbi.nlm.nih.gov/15452284 Zobrazit plný text záznamu